Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Hypoglycemia: Risk increases when using tirzepatide alongside other blood sugarlowering medications
Pen between Patients: Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen: Changes in insulin regimen including, strength, manufacturer, type, injection site or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia
Directions for use: Lather in hands & Wash
Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial
Dosing Recommendations by Hepatic Impairment Severity No published RCT or pharmacokinetic study provides Child-Pugh-stratified ipamorelin dosing
Warnings and Precautions 5.1 Risk of Thyroid C-Cell Tumors In both sexes of rats, tirzepatide caused a dose-dependent and treatment-duration-dependent increase in the incidence of thyroid C-cell tumors (adenomas and carcinomas) in a 2-year study at clinically relevant plasma exposures [see Nonclinical Toxicology (13.1)]
US$ 22.61
US$ 22.75
US$ 22.54
US$ 23.88
US$ 23.86
US$ 29.96
US$ 21.82
US$ 20.25
